Unpublished research calls into question efficacy of common morning sickness drug

January 4, 2017, St. Michael's Hospital
Previously unpublished research calls into question the efficacy of the most commonly prescribed medication for nausea in pregnancy. Information from the 1970s trial was published today in PLOS ONE by Dr. Nav Persaud, a family physician and researcher at St. Michael's Hospital in Toronto. Credit: Courtesy of St. Michael's Hospital

Previously unpublished research calls into question the efficacy of the most commonly prescribed medication for nausea in pregnancy.

The now defunct Merrell-National Laboratories conducted a clinical trial in the 1970s to determine whether the drug pyridoxine-doxylamine, sold under the brand name Diclectin, could alleviate in the first trimester of pregnancy.

While the results of the trial were never published, Health Canada and the U.S. Food and Drug Administration used the information collected to approve the drug, also known as Bendectin in the United States.

Pyridoxine-doxylamine is so popular that it has been prescribed in 33 million women worldwide and is used in half of Canadian pregnancies that result in live births. The Society of Obstetricians and Gynecologists of Canada lists it as the standard of care for women with nausea and vomiting "since it has the greatest evidence to support its efficacy and safety."

The 40-year-old study was published today in the online journal PLOS ONE by Dr. Nav Persaud, a family physician and researcher at St. Michael's Hospital, as part of the restoring invisible and abandoned trials (RIAT) initiative that holds that unpublished or misreported studies make it difficult to determine the true value of a treatment.

Dr. Persaud said there were many flaws in the study, which may explain why it was never published and which call into question the benefits of Diclectin. He obtained 36,000 pages of documents from the FDA, including the original study report, the protocol and summary results, and other documents from Health Canada, all as the result of freedom of information requests.

The trial was conducted at 14 clinics in the United States and enrolled 2,308 patients in the first 12 weeks of pregnancy who were experiencing nausea and vomiting. The women were randomly assigned to eight groups, one of which received a placebo and the other seven a variety of drugs including the combination for Diclectin. Data from 1,599 participants was analyzed. The proportion of participants who were "evaluated moderate or excellent" was greater in each of the seven groups receiving drugs than those receiving the placebo - 14 per cent for Diclectin.

Dr. Persaud called into questions those conclusions based on what he said were several flaws in the execution and analysis of the trial, including:

  • The final results of the study are not available
  • The high number of participants who did not complete the trial, even though it lasted only one week
  • Outcome data is unavailable for 37 per cent of participants in the placebo arm that was used as the reference for comparisons
  • Data for 30 patients recruited by one of the investigators was excluded on orders of the Commissioner of Food and Drugs in a 1975 letter that referred to "data recording in absence of patient visits."
  • The method by which physicians scored symptoms was not clear

Dr. Persaud said he was unable to contact any of the original researchers and there was evidence that many of them had since died.

Explore further: Pyridoxine-doxylamine drug safety data lacking

Related Stories

Pyridoxine-doxylamine drug safety data lacking

April 16, 2014
(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

Preemptive treatment of severe morning sickness decreases suffering for moms-to-be

February 11, 2013
`In a study to be presented on February 14 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Francisco, California, researchers will present data showing the effectiveness of preemptive ...

Naturally occurring symptoms may be mistaken for tamoxifen side-effects

December 9, 2016
Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they suffered nausea and vomiting, according to new data presented at the San Antonio Breast Cancer Symposium today (Friday).

Study finds no evidence linking anti-nausea drug to birth defects

May 9, 2016
Women suffering from extreme morning sickness often take Zofran (ondansetron) to combat their debilitating nausea and vomiting. However, two studies have found that the drug may increase risk of heart defects and cleft palate ...

ACOG: Best evidence for rx of nausea, vomiting in pregnancy

August 20, 2015
(HealthDay)—In a practice bulletin published in the September issue of Obstetrics & Gynecology, recommendations are presented for the management of nausea and vomiting of pregnancy.

'Morning sickness' linked to lower miscarriage risk: study

September 26, 2016
Morning sickness is linked to a lower risk of miscarriage, according to research out Monday that suggests a woman's nausea and vomiting early in pregnancy may have protective effects for the fetus.

Recommended for you

Human Cell Atlas study reveals maternal immune system modifications in early pregnancy

November 14, 2018
The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta. Researchers from the Wellcome Sanger Institute, Newcastle ...

Soy formula feeding during infancy associated with severe menstrual pain in adulthood

November 9, 2018
New research suggests that infant girls fed soy formula are more likely to develop severe menstrual pain as young adults. The finding adds to the growing body of literature that suggests exposure to soy formula during early ...

A major role for a small organ in the immune response during pregnancy

November 9, 2018
The immune system of a pregnant woman is altered during pregnancy, but not in the way previously believed, according to results from a study at Linköping University, Sweden. This study, published in the Journal of Allergy ...

Mailed HPV tests can help find women at-risk for cervical cancer, study finds

November 7, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that mailing self-collection kits to test for high-risk human papillomavirus infection has the potential to boost cervical cancer ...

Women who give birth to boys much more likely to have postnatal depression

November 6, 2018
A University of Kent study into postnatal depression (PND) found the odds of developing this condition increased by 79% when mothers had baby boys compared to baby girls.

New study takes first step toward treating endometriosis

November 1, 2018
Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.